Radiotherapy or systemic therapy versus combined therapy in patients with brain metastases: a propensity-score matched study
Yutaro Koide(Nagoya University Hospital), Takeshi Kodaira(Aichi Cancer Center), Tomoki Kitagawa(Aichi Cancer Center), Takahiro Aoyama(Aichi Cancer Center), Hiroyuki Tachibana(Aichi Cancer Center), Hidetoshi Shimizu(Aichi Cancer Center), Risei Miyauchi(Aichi Cancer Center), Naoya Nagai(Aichi Cancer Center)
Cited by 8
Related Papers
Impact of concurrent antibody–drug conjugates and radiotherapy on symptomatic radiation necrosis in breast cancer patients with brain metastases: a multicenter retrospective study
|Journal of Neuro-Oncology|2024|34
Role of high-dose salvage radiotherapy for oligometastases of the localised abdominal/pelvic lymph nodes: a retrospective study
|BMC Cancer|2020|27
Risk of second primary malignancies after definitive treatment for esophageal cancer: A competing risk analysis
|Cancer Medicine|2019|23
A predictive model for pain response following radiotherapy for treatment of spinal metastases
|Scientific Reports|2021|23